Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavlos Missios

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 18, 2021
[The molecular tumor board]Pavlos Missios, Janina Beha, Michael Bitzer, et al.
NPJ Precision Oncology|April 2, 2025
Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gapsBeryl Primrose Gladstone, Janina Beha, Arisa Hakariya, et al.
Igie : Innovation, Investigation and Insights|February 6, 2026
Transgastric biliary drainage through a biliodigestive efferent loop using a lumen-apposing metal stentKarsten Büringer, Stefano Fusco, Dörte Wichmann, et al.
NPJ Precision Oncology|February 25, 2026
Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsiesAaron Stahl, Karsten Büringer, Pavlos Missios, et al.
The Journal of Experimental Medicine|February 8, 2019
The developmental stage of the hematopoietic niche regulates lineage in <i>MLL-</i>rearranged leukemiaR Grant Rowe, Edroaldo Lummertz da Rocha, Patricia Sousa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotorsTing Tao, Hui Shi, Luca Mariani, et al.
BMJ Open|September 10, 2025
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)Conrad Rauber, Maria Paula Roberti, Maria Jgt Vehreschild, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Nature Communications|September 19, 2014
Glucose substitution prolongs maintenance of energy homeostasis and lifespan of telomere dysfunctional micePavlos Missios, Yuan Zhou, Luis Miguel Guachalla, et al.
The Journal of Clinical Investigation|November 15, 2021
LIN28B alters ribosomal dynamics to promote metastasis in MYCN-driven malignancyPavlos Missios, Edroaldo Lummertz da Rocha, Daniel S Pearson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 18, 2021
[The molecular tumor board]Pavlos Missios, Janina Beha, Michael Bitzer, et al.
NPJ Precision Oncology|April 2, 2025
Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gapsBeryl Primrose Gladstone, Janina Beha, Arisa Hakariya, et al.
Igie : Innovation, Investigation and Insights|February 6, 2026
Transgastric biliary drainage through a biliodigestive efferent loop using a lumen-apposing metal stentKarsten Büringer, Stefano Fusco, Dörte Wichmann, et al.
NPJ Precision Oncology|February 25, 2026
Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsiesAaron Stahl, Karsten Büringer, Pavlos Missios, et al.
The Journal of Experimental Medicine|February 8, 2019
The developmental stage of the hematopoietic niche regulates lineage in <i>MLL-</i>rearranged leukemiaR Grant Rowe, Edroaldo Lummertz da Rocha, Patricia Sousa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotorsTing Tao, Hui Shi, Luca Mariani, et al.
BMJ Open|September 10, 2025
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)Conrad Rauber, Maria Paula Roberti, Maria Jgt Vehreschild, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Nature Communications|September 19, 2014
Glucose substitution prolongs maintenance of energy homeostasis and lifespan of telomere dysfunctional micePavlos Missios, Yuan Zhou, Luis Miguel Guachalla, et al.
The Journal of Clinical Investigation|November 15, 2021
LIN28B alters ribosomal dynamics to promote metastasis in MYCN-driven malignancyPavlos Missios, Edroaldo Lummertz da Rocha, Daniel S Pearson, et al.
Pageof 2